Abstract
In all cases where radiopharmaceuticals are used in clinical practice, consideration of patient safety is of paramount importance and everybody has a contribution to make in achieving this aim. This requires close co-operation between hospitals, manufacturers and authorities to ensure that all materials used are safe, are of suitable quality and are efficacious.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Keeling D.H. & Sampson C.B. Adverse Reactions to Radio-pharmaceuticals. United Kingdom 1977–1983. British Journal of Radiology 1984; 57: 1091–1096.
Atkins H.L. Reported Adverse Reactions to Radiopharmaceuticals remain low in 1984. Journal of Nuclear Medicine 1986; 27: 327.
Ketchum L.E. Radiopharmaceutical Dosimetry Symposium explores new estimates. Journal of Nuclear Medicine 1986; 27: 163–165.
Medicines Act 1968 . Guidance Notes on Applications for Product Licences (MAL 2) 1986 HMSO London.
Medicines Act 1968 . Guidance Notes on Application for Clinical Trials Certificates and Clinical Trial Exemptions 1984 HMSO London.
Gerson M.C., Deutsch E.A., Nishiyama H. et al. Myocardial Perfusion Imaging with 99mTc DMPE in Man European Journal of Nuclear Medicine 1983; 8: 371–374.
Dige-Petersen H. Evaluation of Clinical Information. In: Safety & Efficacy of Radiopharmaceuticals Ed. Kristensen K. & Norbygaard E. Martinus Nijhoff, Boston 1984: 191–202.
Tanabe S., Zodda J.P., Libson K., Deutsch E. & Heinemann W.R. The Biological distributions of some Technetium - MDP components isolated by Anion Exchange High Performance Liquid Chromotography. Int. J. Appl. Radiat. Isotopes 1983; 34: 1585–1592.
Nowotnik D.P., Canning L.R., Cumming S.A. et al. Development of a 99Tcm labelled radiopharmaceutical for cerebral blood Flow imaging. Nuclear Medicine Communications 1985; 6: 499–506.
Sisson J.C., Shapiro B., Beierwaltes W.H. et al. Radiopharmaceutical Treatment of Malignant Phaeochromocytoma. Journal of Nuclear Medicine 1984; 25: 197–206.
Cox PH . Preolinical Studies - Radiopharmacology & Toxicology. In: Safety & Efficacy of Radiopharmaceuticals Ed. Kristensen K. & Norbygaard E. Martinus Nijhoff, Boston 1984: 117–129.
Kazantzis G . Thallium In: Handbook of toxicology of metals. Ed. Friberg L., Nordberg G.F. & Vouk V.B. Elsevier Amsterdam 1986; II: 549–567.
Juul P . Clinical Trials of Radiopharmaceuticals. In: Safety & Efficacy of Radiopharmaceuticals Ed. Kristensen K. & Norbygaard E. Martinus Nijhoff, Boston 1984: 179–190.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Hesslewood, S.R. (1987). Relationships Between Industry, Hospitals and Authorities. In: Kristensen, K., Nørbygaard, E. (eds) Safety and Efficacy of Radiopharmaceuticals 1987. Developments in Nuclear Medicine, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3375-0_24
Download citation
DOI: https://doi.org/10.1007/978-94-009-3375-0_24
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8016-3
Online ISBN: 978-94-009-3375-0
eBook Packages: Springer Book Archive